PAVmed Inc (PAVM)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $13.03M
Last updated: Nov 17, 2026 at 11:05 AM ET
PAVmed Inc (PAVM) Stock Forecast
Analysts expect PAVmed (PAVM) to earn -$2.33 per share in the fiscal year ending Dec 31, 2026, on revenue of $232500. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$2.38.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a larger loss and revenue estimates rise 158.1%.
- Fiscal year ending Dec 31, 2026
- -$2.33
- EPS consensus, revenue $232500
- Fiscal year ending Dec 31, 2027
- -$2.38
- EPS consensus, revenue $600000
- Next report
- Mar 29, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$2.33 | -$2.33 to -$2.33 | 1 | $232500 | $165000 to $300000 | 2 |
| Dec 31, 2027 | -$2.38 | -$2.38 to -$2.38 | 1 | $600000 | $500000 to $700000 | 2 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.57 | N/A | 4 | $132600 | $58800 to $210000 | 4 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 2 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$2.74.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$2.33 | -$2.62 | -$2.62 | -$2.62 | -$2.74 | N/A |
| Fiscal year ending Dec 31, 2027 | -$2.38 | -$2.45 | -$2.45 | -$2.45 | -$2.74 | N/A |
Frequently Asked Questions About PAVM
What is the PAVM stock forecast?
Consensus analyst estimates put PAVmed's EPS at -$2.33 for the fiscal year ending Dec 31, 2026, on revenue of $232500.
What EPS do analysts expect from PAVM next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$2.33, with estimates from -$2.33 to -$2.33 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$2.38, with estimates from -$2.38 to -$2.38 from 1 analyst.
What revenue do analysts expect from PAVmed next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $232500, with estimates from $165000 to $300000. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $600000, with estimates from $500000 to $700000.
How many analysts cover PAVM?
1 analyst estimates EPS for PAVmed for the fiscal year ending Dec 31, 2026.
PAVM pages: Overview, Earnings, Forecast, Financials, Competitors